SLFN11 and lymphoma: Treatment with epigenetic modifiers such as the HDAC inhibitor, Panobinostat, significantly upregulated SLFN11 expression across various GCB-derived lymphoma cell lines, indicating that histone acetylation can reverse the suppression of SLFN11 [41].